Oral, but not transdermal, menopausal HT may raise venous thromboembolism risktranslating…

Oral menopausal hormone therapy was linked to elevated risk for venous thromboembolism, and using high-dose oral estradiol may increase risk for ischemic stroke and myocardial infarction, researchers reported in The BMJ.